OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
To boost compostable packaging, resin innovation, and supply chain speed
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio
Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
Subscribe To Our Newsletter & Stay Updated